A comprehensive A-Z reference of peptide research terminology. Over 45 terms covering peptide science, manufacturing, quality testing, and research protocols.
USE THE LETTER NAVIGATION BELOW TO JUMP TO A SECTION
The fundamental building blocks of peptides and proteins. There are 20 standard amino acids that combine in different sequences to create peptides with distinct biological functions. Each amino acid has an amino group, a carboxyl group, and a unique side chain that determines its chemical properties.
The active growth phase of the hair follicle cycle, during which the hair bulb is fully formed and the hair shaft elongates. Peptides such as GHK-Cu have been researched for their ability to extend the anagen phase, promoting longer and thicker hair growth by stimulating dermal papilla cell activity.
The proportion of an administered compound that reaches systemic circulation in its active form. Subcutaneous research vial delivery achieves significantly higher bioavailability than oral administration, which is subject to first-pass metabolism and enzymatic degradation in the digestive tract. Peptides Pharma's vial system bypasses the GI tract entirely.
Body Protection Compound-157 is a synthetic 15-amino acid peptide derived from a naturally occurring protein found in human gastric juice. It is one of the most extensively studied peptides for tissue repair, gut healing, and neuroprotection. BPC-157 is stable in gastric conditions, unlike most peptides that degrade in acidic environments.
A synthetic analogue of growth hormone-releasing hormone (GHRH) composed of 29 amino acids. CJC-1295 stimulates the pituitary gland to produce sustained growth hormone elevation. It is often researched alongside Ipamorelin for synergistic GH release through complementary pathways.
An official document issued by an independent testing laboratory that certifies the identity, purity, and composition of a peptide product. A complete COA typically includes HPLC chromatogram data, mass spectrometry identity results, endotoxin testing, sterility verification, and batch-specific manufacturing details. Every Peptides Pharma batch ships with a COA.
The most abundant structural protein in the human body, providing tensile strength to skin, tendons, ligaments, and bones. Collagen synthesis naturally declines with age. Peptides such as GHK-Cu have been shown in research to stimulate collagen production, supporting tissue integrity and skin elasticity.
A peptide with a high binding affinity for copper ions. GHK-Cu (glycyl-L-histidyl-L-lysine copper) is the most studied copper peptide, naturally occurring in human plasma, saliva, and urine. It promotes collagen synthesis, wound healing, and has antioxidant and anti-inflammatory properties relevant to skin, hair, and tissue repair research.
A cluster of specialised cells at the base of each hair follicle that regulate hair growth. Dermal papilla cells signal the hair matrix to produce new hair during the anagen phase. GHK-Cu has been shown in research to stimulate dermal papilla cell proliferation, making it a key target for hair growth studies.
A structured schedule defining the dose, frequency, route, and duration of peptide administration in a research setting. Peptides Pharma research vials are designed for 30-day dosing protocols with consistent, precision-measured amounts, eliminating the variability associated with manual syringe preparation from vials.
A quality control assay that detects bacterial endotoxins (lipopolysaccharides) in peptide products. Endotoxin contamination can cause fever, inflammation, and immune reactions. The Limulus Amebocyte Lysate (LAL) test is the gold standard method. All Peptides Pharma batches undergo endotoxin testing as part of the COA process.
Glycyl-L-histidyl-L-lysine copper is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. It declines with age and has been extensively researched for promoting collagen synthesis, wound healing, hair follicle stimulation, antioxidant defence, and anti-inflammatory effects. Peptides Pharma offers a potent 60mg GHK-Cu vial.
A hypothalamic peptide hormone that stimulates the anterior pituitary gland to synthesise and secrete growth hormone. CJC-1295 is a synthetic GHRH analogue that provides longer-lasting GH stimulation than natural GHRH due to its extended half-life and resistance to enzymatic degradation.
An incretin hormone secreted by K-cells in the duodenum in response to nutrient intake. GIP stimulates insulin secretion, promotes fat storage, and influences appetite. Tirzepatide is a dual GIP/GLP-1 receptor agonist, activating both incretin pathways simultaneously for enhanced metabolic effects compared to GLP-1-only compounds.
An incretin hormone produced by L-cells in the intestine that regulates blood glucose by stimulating insulin secretion and suppressing glucagon release. GLP-1 also slows gastric emptying and reduces appetite. Semaglutide and tirzepatide are synthetic GLP-1 receptor agonists studied for metabolic and weight management research.
A regulatory framework ensuring pharmaceutical products are consistently produced and controlled according to quality standards. GMP covers facility design, equipment calibration, personnel training, raw material testing, manufacturing processes, and record keeping. All Peptides Pharma peptides are manufactured in GMP-certified facilities in Switzerland.
A tripeptide (glutamate-cysteine-glycine) that serves as the body's master antioxidant. Glutathione neutralises free radicals, supports cellular detoxification, and plays a critical role in immune function. Injectable glutathione has significantly higher bioavailability than oral supplements, which are largely degraded during digestion.
A 191-amino acid peptide hormone secreted by the anterior pituitary gland that stimulates growth, cell reproduction, and regeneration. GH levels peak during deep sleep and decline with age. Secretagogues such as CJC-1295 and Ipamorelin stimulate the body's own GH production rather than introducing exogenous hormone.
The time required for the concentration of a peptide in the body to decrease by half. Half-life determines dosing frequency and protocol design. For example, CJC-1295 has a half-life of approximately 6-8 days due to albumin binding, whereas natural GHRH has a half-life of only 7 minutes.
An analytical technique used to separate, identify, and quantify components in a mixture. In peptide manufacturing, HPLC is the gold standard for purity analysis. It produces a chromatogram showing peaks that correspond to the target peptide and any impurities. Peptides Pharma peptides are verified to exceed 99% purity via independent HPLC testing.
A selective pentapeptide growth hormone secretagogue that stimulates GH release by binding to the ghrelin receptor on pituitary somatotroph cells. Unlike other GH-releasing peptides, Ipamorelin does not significantly elevate cortisol, prolactin, or ACTH, making it one of the most selective GH secretagogues available for research.
A controlled environment classified under ISO 14644-1 that permits no more than 352,000 particles per cubic metre at 0.5 micrometres. ISO 7 (Class 10,000) cleanrooms are used for sterile pharmaceutical manufacturing, including research vial filling. Peptides Pharma's fill operations take place in HEPA-filtered ISO 7 cleanrooms with continuous environmental monitoring.
Also known as freeze-drying, this preservation technique removes water from a peptide solution by sublimation under vacuum. Lyophilised peptides are stored as stable powders that require reconstitution before use. Peptides Pharma's pre-mixed vial system eliminates the reconstitution step, reducing contamination risk and dosing variability.
An analytical technique that measures the mass-to-charge ratio of ions to identify and characterise molecules. In peptide quality control, mass spectrometry confirms peptide identity by verifying that the observed molecular weight matches the theoretical weight. Peptides Pharma uses mass spectrometry alongside HPLC for comprehensive batch analysis.
A class of peptides that interact with metabolic signalling pathways, influencing processes such as glucose regulation, lipid metabolism, appetite, and energy expenditure. Tirzepatide is a leading example, acting as a dual GIP/GLP-1 receptor agonist to modulate multiple metabolic pathways simultaneously.
An administration strategy involving very small, precisely measured doses of a compound, typically delivered daily. Microdosing aims to maintain steady-state levels while minimising side effects. Peptides Pharma's NAD+ vials enable precise subcutaneous delivery after reconstitution with bacteriostatic water.
A coenzyme present in every living cell that is essential for over 500 enzymatic reactions, including energy metabolism, DNA repair, and sirtuin activation. NAD+ levels decline by up to 50% between ages 40 and 60. Research into NAD+ supplementation explores restoring cellular energy, cognitive function, and healthy aging pathways.
The mechanisms and strategies aimed at preserving neuronal structure and function in the brain and nervous system. Several peptides demonstrate neuroprotective properties in research: BPC-157 supports nerve healing, GHK-Cu has antioxidant effects in neural tissue, and NAD+ supports DNA repair in neurons.
A covalent chemical bond formed between the carboxyl group of one amino acid and the amino group of another through a condensation reaction. Peptide bonds are the linkages that hold amino acids together in a chain. The sequence and number of peptide bonds determine a peptide's structure, stability, and biological activity.
The process of creating peptides by linking amino acids in a specific sequence. Solid-Phase Peptide Synthesis (SPPS) is the dominant manufacturing method, building the peptide chain from C-terminus to N-terminus on a solid resin support. After synthesis, peptides are cleaved from the resin, purified by HPLC, and verified by mass spectrometry.
The study of how the body absorbs, distributes, metabolises, and excretes a drug or compound over time. Pharmacokinetic parameters for peptides include bioavailability, half-life, volume of distribution, and clearance rate. These factors determine optimal dosing protocols and administration frequency.
A pea-sized endocrine gland at the base of the brain that produces and secretes critical hormones including growth hormone, thyroid-stimulating hormone, and adrenocorticotropic hormone. Growth hormone secretagogues such as CJC-1295 and Ipamorelin act on the anterior pituitary to stimulate natural GH release.
The percentage of a peptide sample that consists of the target compound, as opposed to impurities such as truncated sequences, deletion products, or residual solvents. Purity is measured by HPLC and is the most critical quality metric for research peptides. Peptides Pharma peptides are independently verified to exceed 99% purity.
A pre-loaded, precision-dosed delivery device containing a reconstituted peptide solution ready for subcutaneous administration. Peptides Pharma research vials eliminate the need for vial reconstitution, providing consistent dosing, sterile delivery, and 30-day convenience. They represent a significant advancement over traditional vial-and-syringe formats.
The process of dissolving a lyophilised (freeze-dried) peptide powder in a sterile solvent such as bacteriostatic water to create an injectable solution. Reconstitution introduces risks of contamination, incorrect concentration, and peptide degradation. Peptides Pharma vials arrive pre-reconstituted and ready to use, eliminating these risks entirely.
A synthetic peptide manufactured for scientific research and laboratory use. Research peptides are sold strictly for in-vitro study and are not licensed for human self-administration. They must meet stringent purity and quality standards, with each batch accompanied by a Certificate of Analysis from an independent laboratory.
A substance that stimulates the secretion of a specific hormone from an endocrine gland. Growth hormone secretagogues, such as CJC-1295 (GHRH analogue) and Ipamorelin (ghrelin mimetic), promote the body's natural GH production rather than introducing exogenous hormone, preserving the pulsatile pattern of GH release.
A GLP-1 receptor agonist originally developed for type 2 diabetes management, now extensively researched for weight management. Semaglutide activates a single incretin pathway (GLP-1), whereas tirzepatide activates two pathways (GIP + GLP-1). Clinical studies have shown tirzepatide may offer enhanced metabolic benefits due to its dual mechanism of action.
An injection administered into the layer of fat tissue between the skin and muscle, typically in the abdomen, thigh, or upper arm. Subcutaneous delivery is the standard route for research vial administration, providing slower and more sustained absorption compared to intravenous or intramuscular injection.
A synthetic 43-amino acid fragment of Thymosin Beta-4, a naturally occurring protein involved in tissue repair and regeneration. TB-500 promotes cell migration, blood vessel formation, and reduces inflammation. It is one of the most studied peptides for wound healing, cardiac tissue repair, and recovery from musculoskeletal injuries.
A 43-amino acid protein that is the primary G-actin sequestering molecule in eukaryotic cells. Thymosin Beta-4 plays essential roles in cell motility, wound healing, and anti-inflammatory processes. TB-500 is a synthetic version of the full Thymosin Beta-4 protein, retaining its key regenerative properties for research applications.
A dual GIP/GLP-1 receptor agonist that simultaneously activates two incretin hormone pathways involved in glucose regulation, appetite control, and energy metabolism. Tirzepatide represents the cutting edge of metabolic peptide science, with clinical research showing significant effects on body weight, HbA1c, and metabolic markers.
A peptide consisting of exactly three amino acids linked by two peptide bonds. GHK-Cu is a prominent example — composed of glycine, histidine, and lysine with a bound copper ion. Glutathione is another tripeptide, composed of glutamate, cysteine, and glycine. Despite their small size, tripeptides can have potent biological activities.
The widening of blood vessels caused by relaxation of vascular smooth muscle. Increased vasodilation improves blood flow and nutrient delivery to tissues. BPC-157 has been shown in research to promote nitric oxide-mediated vasodilation, which supports tissue healing by enhancing blood supply to damaged areas.
From Research to Results
Every Peptides Pharma research vial is manufactured in GMP-certified facilities, independently tested to exceed 99% purity, and delivered in our precision vial system. Browse our full catalogue of research-grade peptides.
